Importance of surrogate markers in evaluation of antiviral therapy for HIV infection.
Deyton
L
L
HIV Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
D000998:Antiviral Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis*; D018791:CD4 Lymphocyte Count; D018450:Disease Progression; D016903:Drug Monitoring; D006678:HIV / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D012367:RNA, Viral / Q000097:blood
D000998:Antiviral Agents; D015415:Biomarkers; D012367:RNA, Viral